Ipratropium is an
anticholinergic drug (trade name: Atrovent) administered by inhalation for the treatment of
obstructive lung diseases. It acts by blocking
muscarinic receptors in the lung, inhibiting bronchoconstriction and
mucus secretion.
Clinical uses
Ipratropium has respiratory effects similar to atropine but since it is poorly absorbed into the blood, it has few side effects at therapeutic doses. It is available under the trade names Alti-Ipratropium (AltiMed), Apo-Ipravent (Apotex), Atrovent Inhalation Aerosol (Boehringer Ingelheim), Atrovent Inhalation Solution (Boehringer Ingelheim), Atrovent Nasal Spray (Boehringer Ingelheim), Gen-Ipratropium (Genpharm), Novo-Ipramide (Novopharm), Nu-Ipratropium (Nu-Pharm), PMS-Ipratropuim (Pharmascience).
Sources
- Brenner, G. M. (2000). Pharmacology. Philadelphia, PA: W.B. Saunders Company. ISBN 0-7216-7757-6
- Canadian Pharmacists Association (2000). Compendium of Pharmaceuticals and Specialties (25th ed.). Toronto, ON: Webcom. ISBN 0-919115-76-4